TORVANTA
Other · S&P 500 · data as of 2026-10-05

COLL stock analysis: COLL

COLL (COLL) is an S&P 500 company in Other. It grades strongest on profitability and weakest on momentum.

The model's view of COLL · subscribers

Where COLL ranks among the 1,500 U.S. stocks the model scores each trading day, its expected return, the evidence for and against it, and whether the model portfolio holds it. The grades below describe the company's data; they are not the model's view.

See plans
What's happening with COLL · updated 2026-10-05 · from prices and SEC filings

COLL price performance

COLL against the S&P 500, one year
-25%+0%+25%+50%S&P 500 +18%COLL -37%2025-09-292026-10-05
Year to date-52.8%S&P 500 +14.5% · behind by 67.3 pts
1 year-36.8%S&P 500 +17.0% · behind by 53.8 pts
3 years-5.0%S&P 500 +89.3% · behind by 94.3 pts
5 years+11.2%S&P 500 +91.3% · behind by 80.1 pts

Total returns with dividends reinvested.

COLL factor grades

Each grade compares COLL with the rest of its sector (A+ best, F worst); the numbers behind it are shown with the typical figure for its peers.

B+ValueP/E 17.6x (industry 20.1x)FCF yield 46.1% (industry 6.0%)
C+GrowthRevenue growth +14% (industry +8%)EPS growth +19% (industry +10%)
A-ProfitabilityOperating margin 19.5% (industry 9.6%)ROIC 56.1% (industry 10.1%)
FMomentum12-month change -37%From 52-wk high -56%

COLL in plain numbers

COLL key statistics

SectorOther
Industryn/a
IndexS&P 500
Market value$712.0M
Revenue growth (y/y)+14%
Free-cash-flow yield46.1%
Dividend yieldn/a
Next earnings (expected)2026-11-05
Valuation measures
Market value$712.0M
Enterprise value$582.5M
P/E (trailing)17.6x
Forward P/E (Torvanta estimate)19.3x
Price / sales0.9x
Price / book2.3x
EV / revenue0.7x
EV / EBITDA3.7x
Financial highlights
Revenue, last 12 months$808.2M
Net income, last 12 months$47.9M
EPS, last 12 months (GAAP)$1.24
Gross margin60.0%
Operating margin19.5%
Net margin5.9%
Return on equity17.6%
Return on invested capital56.1%
Cash$129.5M
Free cash flow, last 12 months$328.3M
Interest cover2.1x
Current ratio1.03x

Company figures from its latest SEC filings; market value and returns from end-of-day prices.

COLL earnings trends

Revenue vs earnings
-$15.1M$41.1M$97.2M$153.3M$209.4MSep 2024 Revenue: $159.3MDec 2024 Revenue: $181.9MMar 2025 Revenue: $177.8MJun 2025 Revenue: $188.0MSep 2025 Revenue: $209.4MDec 2025 Revenue: $205.4MMar 2026 Revenue: $193.5MJun 2026 Revenue: $199.9MSep 2024 Net income: $9.3MDec 2024 Net income: $12.5MMar 2025 Net income: $2.4MJun 2025 Net income: $12.0MSep 2025 Net income: $31.5MDec 2025 Net income: $17.0MMar 2026 Net income: $14.5MJun 2026 Net income: -$15.1MSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Net margin: 5.9%Net margin: 6.9%Net margin: 1.4%Net margin: 6.4%Net margin: 15.0%Net margin: 8.3%Net margin: 7.5%Net margin: -7.5%-8%4%15%■ Revenue ■ Net income ━ Net margin
Earnings per share$-0.5$-0.1$0.2$0.5$0.8Sep 2024 EPS (GAAP, diluted): $0.3Dec 2024 EPS (GAAP, diluted): $0.4Mar 2025 EPS (GAAP, diluted): $0.1Jun 2025 EPS (GAAP, diluted): $0.3Sep 2025 EPS (GAAP, diluted): $0.8Dec 2025 EPS (GAAP, diluted): $0.5Mar 2026 EPS (GAAP, diluted): $0.4Jun 2026 EPS (GAAP, diluted): $-0.5Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026■ EPS (GAAP, diluted) Change from a year earlier: Sep 2025 +211% · Dec 2025 +28% · Mar 2026 +471% · Jun 2026 -235%

From the company's 10-Q and 10-K filings with the SEC.

COLL financials (from SEC filings)

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$276.9M$463.9M$566.8M$631.4M$780.6M
Net income$71.5M-$25.0M$48.2M$69.2M$62.9M
EPS (GAAP)$1.69$-0.74$1.18$1.86$1.71
Free cash flow$101.6M$122.6M$274.3M$203.3M$327.6M

COLL earnings history

ReportedEPS (GAAP)EPS y/yRevenue y/yStock vs S&P 500, 2 days
2026-08-06$-0.46-235%+6%-18.0%
2026-05-07$0.40+471%+9%+3.0%
2026-02-26$0.46+28%+13%-7.9%
2025-11-06$0.84+211%+31%+19.0%
2025-08-07$0.34-35%+29%+16.7%
2025-05-08$0.07-90%+23%+6.2%

About COLL

HeadquartersStoughton, MA
Industry (SEC code)Pharmaceutical Preparations
Fiscal year endsDecember 31
Incorporated inVA
Listed onNasdaq
FormerlyCOLLEGIUM PHARMACEUTICAL INC

From the company's SEC registration record.

Companies similar to COLL

CompanyMarket valueP/ERevenue growthOperating margin12-month change
COLL COLL$712.0M17.6x+14%19.5%-37%
SCHL SCHL$707.0M26.3x-3%1.0%+33%compare
WGO WGO$706.7M18.4x+3%2.4%-25%compare
BFS BFS$730.4M30.2x+9%67.0%+1%compare
ADAM ADAM$693.9M4.6xn/an/a+25%
APOG APOG$744.2M11.2x+2%6.9%-17%
SABR SABR$778.9M1.2x-3%11.3%+4%

All Other stock ratings

Frequently asked questions

Is COLL stock a buy?

Torvanta does not tell individuals what to buy. Its grades for COLL are shown above. Subscribers see the model's rank, expected return and whether the model portfolio holds it. This is research, not a recommendation.

What is COLL's P/E ratio?

COLL trades at about 17.6 times its last 12 months of GAAP earnings reported to the SEC, and about 19.3 times Torvanta's own estimate of the next 12 months.

When does COLL report earnings next?

Based on its filing history, Torvanta expects COLL to report around 2026-11-05.

How has COLL performed against the S&P 500?

Over the past year COLL returned -36.8%, against +17.0% for the S&P 500, dividends reinvested.

See the model's view

Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.

See plans Or get the free weekly newsletter

Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.

All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer